Quantum Biopharma QNTM
NASDAQ QNTM
$2.40 -0.03 (-1.23%)
At close: Oct 21, 2026 · 4:00 PM EDT

Quantum Biopharma (QNTM) EBITDA Margin (2021 - 2025)

Updated

Quantum Biopharma (QNTM) reported EBITDA Margin of -184584.75% for FY2020, down 171545.68 percentage points from -13039.07% in FY2019.

Analysis

Quantum Biopharma (QNTM) EBITDA Margin (2021 - 2025) Analysis & Trends

  • According to Business Quant data, EBITDA Margin came in at -13039.07% in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 35.95%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 49.01%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 6.02%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.11%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 46.01%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -124.26%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 39.16%
10 Quantum Biopharma 7.89 Mn -2.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -4,513.83%
Jun 30, 2025 -5,193.32%
Mar 31, 2025 -4,861.54%
Dec 31, 2024 184,896.14%
Sep 30, 2024 -2,477.76%
Jun 30, 2024 -3,179.15%
Mar 31, 2024 -1,238.79%
Dec 31, 2023 22,531.21%
Dec 31, 2022 80,478.34%
Dec 31, 2021 13,641,969.78%
API Access

Quantum Biopharma EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=QNTM&period=max&api_key=YOUR_API_KEY